Induction of remission in Wegener's granulomatosis with low dose methotrexate

Journal of Rheumatology

Volumn 25, Issue 3, 1998, Pages 492-495

  De Groot, Kirsten ^a   Mühler, Martin ^a   Reinhold Keller, Eva ^a   Paulsen, Jens ^b   Gross, Wolfgang L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Induction of remission; Low dose methotrexate; Wegener's granulomatosis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DAPSONE; METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GLOMERULONEPHRITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE; REMISSION; STEROID THERAPY; WEGENER GRANULOMATOSIS;

ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLIC ACID ANTAGONISTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; REMISSION INDUCTION; WEGENER GRANULOMATOSIS;

EID: 2642671151     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
2. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
3. Hoffman GS, Leavitt RY, Kerr GS, Fauci AS. The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum 1992;35:1322-9.
4. Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 1995;38:608-13.
5. de Groot K, Reinhold-Keller E, Tatsis E, Paulsen J, Heller M, Gross WL. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 1996;39:2052-61.
6. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
7. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: The proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-92.
8. Reinhold-Keller E, de Groot K, Rudert H, Nölle B, Heller M, Gross WL. Response to thrimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease. Q J Med 1996;89:15-23.
9. Muhle C, Reinhold-Keller E, Richter C, et al. MRI of the nasal cavity, paranasal sinuses and orbit in Wegener's granulomatosis. Eur Radiol 1997;7:566-70.
10. Nölle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989;111:28-40.
11. Reinhold-Keller E, Kekow J, Schnabel A, et al. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 1994; 37:919-24.
12. Körber H, Iven H, Gross WL. Bioavailability and pharmacokinetics of methotrexate (MTX) and its metabolite 7-hydroxy-MTX (7-OH-MTX) after low-dose MTX (25 mg) in patients with chronic rheumatic diseases[abstract). Arthritis Rheum 1992; 35 Suppl:S142.